Table 1.
Comparison of the clinical characteristics of the enrolled patients in the training and test sets.
| Characteristics | Training cohort(n=129) | Test cohort (n=44) | ||||||
|---|---|---|---|---|---|---|---|---|
| MIBC | non- MIBC | ALL | P value | MIBC | non- MIBC | ALL | P value | |
| Age | 68.1250 ± 10.7065 | 66.7216 ± 12.9605 | 67.0698 ± 12.4142 | 0.58122896 | 62.2727 ± 8.7646 | 64.4545 ± 12.5202 | 63.9091 ± 11.6376 | 0.596155872 |
| Exact number of lesions | 1.2500 ± 0.6222 | 1.2577 ± 0.7675 | 1.2558 ± 0.7319 | 0.95891122 | 1.3636 ± 0.6742 | 1.1212 ± 0.3314 | 1.1818 ± 0.4458 | 0.119461671 |
| Gender | 0.91801102 | 0.100118555 | ||||||
| Male | 6(0.1875) | 19(0.1959) | 25(0.1938) | null | 7(0.2121) | 7(0.1591) | ||
| Female | 26(0.8125) | 78(0.8041) | 104(0.8062) | 11(1.0000) | 26(0.7879) | 37(0.8409) | ||
| Hydronephrosis | <0.001 | <0.001 | ||||||
| Yes | 12(0.3750) | 5(0.0515) | 17(0.1318) | 4(0.3636) | null | 4(0.0909) | ||
| No | 20(0.6250) | 92(0.9485) | 112(0.8682) | 7(0.6364) | 33(1.0000) | 40(0.9091) | ||
| Therapeutic approach | 0.05545129 | 0.014801282 | ||||||
| Cystectomy | 9(0.2812) | 13(0.1340) | 22(0.1705) | 3(0.2727) | 1(0.0303) | 4(0.0909) | ||
| TURBT | 23(0.7188) | 84(0.8660) | 107(0.8295) | 8(0.7273) | 32(0.9697) | 40(0.9091) | ||
| Number of lesions | 0.77081506 | 0.24399552 | ||||||
| Multiple | 6(0.1875) | 16(0.1649) | 22(0.1705) | 3(0.2727) | 4(0.1212) | 7(0.1591) | ||
| Single | 26(0.8125) | 81(0.8351) | 107(0.8295) | 8(0.7273) | 29(0.8788) | 37(0.8409) | ||
SD, standard deviation; MIBC, muscle-invasive bladder cancer; non- MIBC, non-muscle-invasive bladder cancer.